FdaApplication
ANDA 070752
Identifiers
- fda_app_no: ANDA070752
Properties
| Property | Value |
|---|---|
| applicant_name | ABRAXIS PHARMACEUTICAL PRODUCTS |
| application_type | ANDA |
| approval_date | 1986-09-24 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALBUPHINE | NALBUPHINE HYDROCHLORIDE | 20MG/ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| NALBUPHINE | NALBUPHINE HYDROCHLORIDE | 200MG/10ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products